As per our report, the size of the Global Specialty Enzymes Market estimated to grow at a CAGR of 9.1%, to reach from 2019 to 2024.
Specialty enzymes have picked up prevalence in the current years inferable from their potential applications in different enterprises, for example, pharmaceutical, biotechnology research, and diagnostics. Specialty enzymes are proteins that go about as biocatalysts to quicken responses and deliver the coveted outcomes in pharmaceuticals and diagnostics responses. In the pharmaceuticals business, specialty enzymes assume a noteworthy part in the sedate definition and medication conveyance.
Chemical-based pharmaceutical medication definitions are utilized for the treatment of endless conditions, for example, disease and AIDS. Specialty enzymes have been generally utilized as a part of the biotechnology business for inquiring about, especially in the sub-atomic science. They are additionally utilized as a part of hereditary designing methods to cut, reproduce and append DNA according to the prerequisite. The specialty enzymes required for diagnostics must be of the most purity and in little amount, which brings about the high cost and less reception of indicative enzymes. The global Specialty Enzymes market is developing at an exceptionally quick pace.
The increasing number of biotechnology R&D and development in enzyme engineering and green chemistry are significant growth drivers of the market. Also, the surge growing industrialization rate and advanced technologies adopted in the pharmaceutical industry in developing economies will boost this industry. Difficulty in maintaining pH and operational temperature of specialty enzymes limits this industry.
Silicone Specialty Enzymes find application in casting and molding for providing separation of mold and reduce imperfections in the surface. The use of these products results in inducing less material waste, faster throughput and longer life of mold and machinery.
Market Size Available
2018 – 2024
2019 – 2024
By Source, Type, Application, and Region
North America (United States and Canada), Europe (UK, Spain, Germany, Italy, France and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, New Zealand, Rest of APAC), Latin America (Brazil, Argentina, Mexico and Rest of Latin America), Middle East and Africa
Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies,Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Roche Holding Ag., and Sanofi S.A
This research report on the Global Specialty Enzymes Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.
Specialty Enzymes Market - By Source:
Specialty Enzymes Market - By Type:
Specialty Enzymes Market - By Application:
North America is estimated to constitute the largest share in this market, while the Asia Pacific region is expected to witness the fastest growth and overtake North America, being the second-largest shareholder for the market during the forecast period.
Key industry players leading the Global Specialty Enzymes Market profiled in this report are:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.5 Y-o-Y Growth Analysis, By Source
5.1.6 Market Attractiveness Analysis, By Source
5.1.7 Market Share Analysis, By Source
188.8.131.52 Other Carbohydrases
5.2.4 Polymerases &Nucleases
5.2.7 Specialty Enzymes Used in Pharmaceuticals
5.2.8 Specialty Enzyme Used in Diagnostics
5.2.9 Specialty Enzyme Used For Research & Biotechnology
5.2.10 Y-o-Y Growth Analysis, By Type
5.2.11 Market Attractiveness Analysis, By Type
5.2.12 Market Share Analysis, By Type
184.108.40.206 Enzyme Replacement Therapy
220.127.116.11 Thrombolytic Enzymes
18.104.22.168 Digestive Enzymes
5.3.3 Research & Biotechnology
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Source
188.8.131.52 By Type
184.108.40.206 By Application
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Source
22.214.171.124 By Type
126.96.36.199 By Application
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Source
220.127.116.11 By Type
18.104.22.168 By Application
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Affymetrix Inc.
8.1.2 Source Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 BBI Enzymes Ltd.
8.3 Nagase & Co. Ltd.
8.4 Life Technologies
8.5 Advanced Enzyme Technology Ltd.
8.6 Roche Holding Ag
8.7 Sanofi S.A.
8.8 Codexis Inc.
8.9 Amano Enzyme Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures